Literature DB >> 17261506

Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.

Masayoshi Minegishi1, Tsuneo Itoh, Narumi Fukawa, Tamie Kitaura, Junko Miura, Hiroyuki Takahashi, Akira Suzuki, Yoshinori Kudo, Ayuko Narita, Yuko Sato, Masakuni Suzuki, Takanori Watanabe, Yuichi Wada, Yoichi Takeyama, Shigeru Tsuchiya.   

Abstract

The aim of this study was to evaluate how a simple method of cryopreservation influences the quality of CD34+ cells in umbilical cord blood (UCB). The cells were dispensed into a double-compartment freezing bag, cryopreserved at -85 degrees C without a rate-controlled programmed freezer, and stored in the liquid phase of nitrogen. The viability of the CD34+ cells before freezing and after thawing was assessed by flow cytometry with 7-aminoactinomycin D and by colony-forming assays. Twenty UCB units cryopreserved for a median of 92 days were analyzed. Mean CD34+ cell viabilities before freezing were 99.8% +/- 0.4% and after thawing were 99.5% +/- 0.8% in large chambers, 99.6% +/- 0.5% in small chambers, and 99.4% +/- 0.6% in sample tubes. The mean values from colony-forming assays of the viable CD34+ cells before freezing were 30.7 +/- 6.8 (colony-forming units-granulocyte-macrophage [CFU-GM] per 100 viable CD34+ cells) and 68.5 +/- 14.8 (total CFUs per 100 viable CD34+ cells). The CFU-GM and total CFU values after thawing were, respectively, 32.7 +/- 9.0 and 66.0 +/- 13.4 in large chambers, 32.4 +/- 8.1 and 64.5 +/- 16.1 in small chambers, and 30.9 +/- 5.4 and 64.7 +/- 12.4 in sample tubes. The results of the colony-forming assays before freezing and after thawing were not significantly different. Our findings overall indicated that our simple method for the cryopreservation of UCB cells without a rate-controlled programmed freezer does not impair the clonogenic capacity of UCB progenitor cells. This cryopreservation method could provide cellular products adequate for hematopoietic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261506     DOI: 10.1532/IJH97.06147

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood.

Authors:  L Lazzari; S Lucchi; T Montemurro; L Porretti; R Lopa; P Rebulla; G Sirchia
Journal:  Bone Marrow Transplant       Date:  2001-10       Impact factor: 5.483

2.  Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank.

Authors:  Tokiko Nagamura-Inoue; Mika Shioya; Michiko Sugo; Yan Cui; Atsuko Takahashi; Satomi Tomita; Yizhou Zheng; Kei Takada; Hideki Kodo; Shigetaka Asano; Tsuneo A Takahashi
Journal:  Transfusion       Date:  2003-09       Impact factor: 3.157

3.  Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved by a simple controlled-rate freezing method.

Authors:  Yoshinori Kudo; Masayoshi Minegishi; Tsuneo Itoh; Junko Miura; Naoko Saito; Hiroyuki Takahashi; Akira Suzuki; Ayuko Narita; Yuko Sato; Jun-ichi Kameoka; Masue Imaizumi; Makoto Sato; Yasuko Murakawa; Shigeru Tsuchiya
Journal:  Tohoku J Exp Med       Date:  2005-01       Impact factor: 1.848

4.  Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.

Authors:  M Keeney; I Chin-Yee; K Weir; J Popma; R Nayar; D R Sutherland
Journal:  Cytometry       Date:  1998-04-15

5.  Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.

Authors:  C Almici; C Carlo-Stella; J E Wagner; L Mangoni; D Garau; A Re; R Giachetti; C Cesana; V Rizzoli
Journal:  Bone Marrow Transplant       Date:  1997-06       Impact factor: 5.483

6.  Effect of cryopreservation period on rat tracheal allografts.

Authors:  R Nakanishi; M Hashimoto; H Muranaka; K Yasumoto
Journal:  J Heart Lung Transplant       Date:  2001-09       Impact factor: 10.247

7.  Optimal cryopreservation of human umbilical cord blood.

Authors:  C Donaldson; W J Armitage; P A Denning-Kendall; A J Nicol; B A Bradley; J M Hows
Journal:  Bone Marrow Transplant       Date:  1996-10       Impact factor: 5.483

8.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

9.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Collection, separation and cryopreservation of umbilical cord blood for use in transplantation.

Authors:  D T Harris; M J Schumacher; S Rychlik; A Booth; A Acevedo; P Rubinstein; J Bard; E A Boyse
Journal:  Bone Marrow Transplant       Date:  1994-02       Impact factor: 5.483

View more
  2 in total

1.  Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation.

Authors:  Shohei Yamamoto; Hirokazu Ikeda; Daisuke Toyama; Mayumi Hayashi; Kousuke Akiyama; Manabu Suzuki; Yutaka Tanaka; Tsuneki Watanabe; Yoko Fujimoto; Ichirou Hosaki; Hirokazu Nishihira; Keiichi Isoyama
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

2.  Quality assessment of umbilical cord blood units at the time of transplantation.

Authors:  Yoshinori Kudo; Masayoshi Minegishi; Osamu Seki; Hiroyuki Takahashi; Akira Suzuki; Ayuko Narita; Yuko Sato; Machiko Abe; Natsuko Ishioka; Hideo Harigae; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.